A systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulants vs vitamin K antagonists after transcatheter aortic valve replacement in patients with atrial fibrillation

被引:0
作者
Amanda Jia Qi Ooi
Chloe Wong
Timothy Wei Ern Tan
Trina Priscilla Ng
Yao Neng Teo
Yao Hao Teo
Nicholas L. Syn
Andie H. Djohan
Yinghao Lim
Leonard L. L. Yeo
Benjamin Y. Q. Tan
Mark Yan-Yee Chan
Kian-Keong Poh
William K. F. Kong
Ping Chai
Tiong-Cheng Yeo
James W. Yip
Ivandito Kuntjoro
Ching-Hui Sia
机构
[1] National University of Singapore,Yong Loo Lin School of Medicine
[2] National University Heart Centre,Department of Cardiology
[3] National University Hospital,Division of Neurology, Department of Medicine
来源
European Journal of Clinical Pharmacology | 2022年 / 78卷
关键词
Transcatheter aortic valve replacement (TAVR); Atrial fibrillation (AF); Non-vitamin K antagonists oral anticoagulants (NOAC); Vitamin K antagonist (VKA); Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1589 / 1600
页数:11
相关论文
共 81 条
[1]  
Carroll JD(2020)STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement J Am Coll Cardiol 76 2492-2516
[2]  
Mack MJ(2019)TAVR-present, future, and challenges in developing countries Indian J Thorac Cardiovasc Surg 35 473-484
[3]  
Vemulapalli S(2017)Impact of atrial fibrillation on outcomes of patients treated by transcatheter aortic valve implantation: a systematic review and meta-analysis Am Heart J 192 64-75
[4]  
Bana A(2021)Post-operative atrial fibrillation impacts on outcomes in transcatheter and surgical aortic valve replacement Front Cardiovasc Med 8 789548-789648
[5]  
Mojoli M(2021)2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC Eur Heart J 42 373-498
[6]  
Gersh BJ(2007)Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation Ann Intern Med 146 857-867
[7]  
Barioli A(2010)Warfarin–indications, risks and drug interactions Aust Fam Physician 39 476-479
[8]  
Jeong HK(2008)Warfarin therapy: in need of improvement after all these years Expert Opin Pharmacother 9 677-686
[9]  
Yoon N(2021)Changes in anticoagulant prescription patterns over time for patients with atrial fibrillation around the world J Arrhythmia 37 990-1006
[10]  
Kim JH(2013)Pros and cons of new oral anticoagulants Hematology Am Soc Hematol Educ Program 2013 464-470